Report #2829555

Overview

Sex

Male

Age

Age unknown

State

CA

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (3)

Symptom narrative

The patient with lactose intolerance received dose of Vivotif; The patient with lactose intolerance received dose of Vivotif; Case reference number US-BN-2024-002698 is a spontaneous case initially received from a nurse via Med Communication (reference number: USBAV24-2751) on 17-Oct-2024 and concerns a male patient of unknown age. The patient's medical history and concomitant medication were not provided. The patient's current condition included lactose intolerance. On unspecified date, the patient took a dose of Vivotif (batch number: unknown) at unknown dose, or route of administration for unknown indication. As reported, the patient was lactose intolerant (explicitly coded as 'contraindicated product administered' and 'labelled drug-disease interaction error'). At the time of the initial report, the patient did not experience any adverse events due to Vivotif, since it was reported that patient did not have any incidence. The case is linked with the case US-BN-2024-002661, containing the same reporter. No further information was provided.; Reporter's Comments: A male patient of unknown age took a dose of Vivotif, at unknown dose, route of administration for unknown indication. Reportedly, the patient was lactose intolerant which is considered as contraindicated product administered and labelled drug-disease interaction medication error. Contraindicated product administered and labelled drug-disease interaction medication error are both considered listed per company conventions. At this point, the patient did not experience any adverse events due to Vivotif. The patient's medical history and concomitant medication information was not provided while current condition included lactose intolerance. Contraindicated product administered and labelled drug-disease interaction error are not related to Vivotif, but to human error. The case is non-serious.; Sender's Comments: A male patient of unknown age took a dose of Vivotif, at unknown dose, route of administration for unknown indication. Reportedly, the patient was lactose intolerant which is considered as contraindicated product administered and labelled drug-disease interaction medication error. Contraindicated product administered and labelled drug-disease interaction medication error are both considered listed per company conventions. At this point, the patient did not experience any adverse events due to Vivotif. The patient's medical history and concomitant medication information was not provided while current condition included lactose intolerance. Contraindicated product administered and labelled drug-disease interaction error are not related to Vivotif, but to human error. The case is non-serious.

Current illness

Lactose intolerant